Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Johnson and Johnson
McKinsey
Express Scripts
Harvard Business School

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Chlorhexidine gluconate; isopropyl alcohol - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chlorhexidine gluconate; isopropyl alcohol and what is the scope of freedom to operate?

Chlorhexidine gluconate; isopropyl alcohol is the generic ingredient in ten branded drugs marketed by 3m Health Care, Becton Dickinson Co, and Prof Dspls, and is included in four NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorhexidine gluconate; isopropyl alcohol has forty-two patent family members in fourteen countries.

There are fifty-eight drug master file entries for chlorhexidine gluconate; isopropyl alcohol. Four suppliers are listed for this compound.

Summary for chlorhexidine gluconate; isopropyl alcohol
International Patents:42
US Patents:7
Tradenames:10
Applicants:3
NDAs:4
Drug Master File Entries: 58
Suppliers / Packagers: 4
Clinical Trials: 15
DailyMed Link:chlorhexidine gluconate; isopropyl alcohol at DailyMed
Recent Clinical Trials for chlorhexidine gluconate; isopropyl alcohol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto de Investigacion Sanitaria La FePhase 4
Gama Healthcare Ltd.Phase 3
Northwestern UniversityPhase 4

See all chlorhexidine gluconate; isopropyl alcohol clinical trials

US Patents and Regulatory Information for chlorhexidine gluconate; isopropyl alcohol

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prof Dspls PREVANTICS SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021524-002 Jun 3, 2005 OTC Yes Yes   Start Trial   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-007 Oct 10, 2006 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Expired US Patents for chlorhexidine gluconate; isopropyl alcohol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-004 Aug 20, 2003   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-005 Apr 3, 2006   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-001 Jul 14, 2000   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-001 Jul 14, 2000   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Harvard Business School
Medtronic
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews